Lonza sells capsules, health ingredients business to Lone Star Funds for CHF2.3B

Mar 9, 2026

Lonza divests capsules and health ingredients business to Lone Star Funds for CHF 2.3 billion, finalizing its shift to a pure-play CDMO model by H2 2026.